Children Primary Nephropathy Iga clinical trials

Explore recruiting children primary nephropathy iga clinical trials.

Also recruiting in Europe

Children Primary Nephropathy Iga trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SABINE - The efficacy and Safety of delayed-release Budesonide in children with primary IgA nephropathy - a multicenter, interventional phase III, randomized, placebo-controlled, double-blind study.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Children Primary Nephropathy Iga trials by city

Children Primary Nephropathy Iga in Toronto Children Primary Nephropathy Iga in Vancouver Children Primary Nephropathy Iga in Montreal Children Primary Nephropathy Iga in Calgary Children Primary Nephropathy Iga in Edmonton Children Primary Nephropathy Iga in Ottawa Children Primary Nephropathy Iga in Winnipeg Children Primary Nephropathy Iga in Quebec City Children Primary Nephropathy Iga in Hamilton Children Primary Nephropathy Iga in Kitchener Children Primary Nephropathy Iga in London Children Primary Nephropathy Iga in Halifax Children Primary Nephropathy Iga in New York Children Primary Nephropathy Iga in Los Angeles Children Primary Nephropathy Iga in Chicago Children Primary Nephropathy Iga in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease